Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial by Paolo Strati, Lei Feng, Jason R. Westin, Ranjit Nair, Luis E. Fayad, Maria A. Rodriguez, Dai Chihara, Luis Malpica, Jared Henderson, Mariana Gallardo, Marissa Rivera, Iris Wang, Anastasiia Bolshakova, Anastasia Radko, David Kurtz, Stefan K. Alig, Christopher R. Flowers, Ash A. Alizadeh, Sattva S. Neelapu

Get full text